PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35123232-0	2022	Nicotinamide mononucleotide increases cell viability and restores tight junctions in high-glucose-treated human corneal epithelial cells via the SIRT1/Nrf2/HO-1 pathway.	Nicotinamide Mononucleotide	0-27	heme oxygenase 1	Homo sapiens	156-160	
33373320-5	2020	NMN administration significantly increased NAD+ levels, SIRT1 protein expression, and heme oxygenase-1 (HO-1) expression.	Nicotinamide Mononucleotide	0-3	heme oxygenase 1	Homo sapiens	86-102	
33373320-5	2020	NMN administration significantly increased NAD+ levels, SIRT1 protein expression, and heme oxygenase-1 (HO-1) expression.	Nicotinamide Mononucleotide	0-3	heme oxygenase 1	Homo sapiens	104-108